NFKB1 and pancreatic neoplasm: Our study also reveals that there was no difference in the establishment of pancreatic cancer between NEMO-expressing and NEMO-ablated KPC mice, suggesting that the NF-κB pathway may be dispensable for the progression of high-grade PanINs towards pancreatic cancer on the background of ablated p53.